FITLIFE BRANDS, INC. Stock Split Ratio
FITLIFE BRANDS, INC. (FTLF) had Stock Split Ratio of 200.00% as of 2025-02-07, per its 10-K filed 2026-03-31.
Financial Statements › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2026-03-31
- 2025-02-07: Stockholders' Equity Note, Stock Split, Conversion Ratio 200.00%.
- 2021-12-02: Stockholders' Equity Note, Stock Split, Conversion Ratio 400.00%.
- 2019-04-11: Stockholders' Equity Note, Stock Split, Conversion Ratio 80000.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2025-02-07 | 200.00% 10-K · filed 2026-03-31 |
| 2021-12-02 | 400.00% 10-K · filed 2023-03-24 |
| 2019-04-11 | 80000.00% 10-K/A · filed 2022-10-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |